Michael Rosenblatt

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective
    Michael Rosenblatt
    Department of Medicine, Division of Bone and Mineral Metabolism, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Bone Miner Res 18:1142-5. 2003

Detail Information

Publications1

  1. ncbi Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective
    Michael Rosenblatt
    Department of Medicine, Division of Bone and Mineral Metabolism, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Bone Miner Res 18:1142-5. 2003
    ....